Saturday 17 October 2026
Export SVA’s income statement to Excel — free account
Sinovac Biotech, Ltd.
Sinovac Biotech, Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $386.0 million, up 6.82% from fiscal 2024.
6.47
0.00
0.00%
Follow SVA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.19 | 0.19 | 0.19 | 0.08 | 0.07 | 6.05 | 16.18 | 12.44 | 13.59 | 0.00 |
Piotroski F-Score |
3 | 3 | 4 | 3 | 8 | 4 | 4 | 6 | 7 | 2 |
P/S ratio |
0.06 | 0.06 | 0.06 | 0.03 | 0.03 | 1.25 | 2.49 | 1.96 | 1.95 | 4.64 |
Altman Z-Score |
1.22 | 1.70 | 1.61 | 1.93 | 6.24 | 1.80 | 5.60 | 5.31 | 3.78 | 3.11 |
Altman Z″-Score (non-manufacturers) |
8.06 | 11.71 | 12.45 | 16.10 | 18.40 | 5.55 | 8.93 | 8.98 | 5.08 | 3.50 |
P/FCF ratio |
0.00 | 0.00 | 0.14 | 0.05 | 0.04 | 1.82 | 21.56 | 190.99 | 9.63 | 0.00 |
Beneish M-Score |
(2.38) | (2.70) | (2.49) | 1.38 | 29.51 | (2.09) | (1.53) | (1.98) | (2.10) | (1.89) |
P/Operating CF |
(2.06) | (1.46) | 1.33 | 1.33 | 1.33 | 1.33 | 23.21 | 58.38 | 7.88 | 47,999.87 |
Dividend Safety Score |
20 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.10 | 0.06 | 0.05 | 0.07 | 0.07 | 0.57 | 1.74 | 1.54 | 3.03 | 2.59 |
Price to Tangible BV |
0.10 | 0.06 | 0.05 | 0.07 | 0.07 | 0.57 | 1.74 | 1.54 | 3.03 | 2.59 |
EV/Sales |
(0.88) | (0.96) | (1.02) | (0.51) | (0.64) | (0.99) | 1.69 | 1.25 | 1.63 | 4.30 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.68 | 5.70 | 5.59 | 55.92 |
EV/Operating CF |
34.78 | (164.15) | (1.84) | (0.72) | (0.80) | (1.05) | 10.62 | 36.01 | 6.34 | (20.14) |
EV/FCF |
12.47 | 12.01 | (2.17) | (0.76) | (0.83) | (1.43) | 14.58 | 121.62 | 8.03 | (11.08) |
Quick Ratio |
4.51 | 7.25 | 8.86 | 10.93 | 5.96 | 2.12 | 3.67 | 4.37 | 1.97 | 1.74 |
Current Ratio |
4.59 | 7.33 | 8.97 | 11.11 | 6.18 | 2.30 | 4.01 | 4.88 | 2.20 | 1.97 |
Net Debt/EBITDA |
15.70 | 24.96 | 19.39 | 36.34 | (0.76) | (5.21) | (2.72) | (3.25) | (1.52) | (4.44) |
Debt/Assets |
5.79% | 3.05% | 1.87% | 0.08% | 0.12% | 2.17% | 1.63% | 3.76% | 13.39% | 19.27% |
Debt/Equity |
0.08 | 0.04 | 0.02 | 0.00 | 0.00 | 0.04 | 0.02 | 0.05 | 0.23 | 0.31 |
Asset Turnover |
0.04 | 0.03 | 0.03 | 0.10 | 2.08 | 0.43 | 0.60 | 0.69 | 0.68 | 0.35 |
Operating CF/Net income |
8.58 | (0.63) | (10.28) | (7.14) | 1.81 | 4.59 | 0.98 | 0.36 | 2.32 | 25.94 |
Capex/Depreciation |
(0.49) | (0.88) | (0.99) | (2.60) | (8.51) | (33.60) | (2.32) | (1.14) | (2.56) | (2.49) |
Interest Coverage |
(49.92) | (89.68) | (144.50) | (368.72) | 6,189.44 | 148.41 | 105.48 | 42.35 | 28.95 | 0.29 |
| (0.72%) | 0.83% | (0.11%) | 0.81% | 112.85% | 14.18% | 12.36% | 9.29% | 16.82% | (0.45%) | |
| (0.57%) | 0.70% | (0.10%) | 0.70% | 90.74% | 8.87% | 9.68% | 6.51% | 10.11% | (0.29%) | |
ROIC |
(121.75%) | (69.65%) | (51.13%) | (20.75%) | 2,332.85% | 0.00% | 27.93% | 22.00% | 28.04% | 0.30% |
Return on Tangible Assets |
(0.96%) | 0.90% | (0.12%) | 0.90% | 63.12% | 9.65% | 11.82% | 7.34% | 13.74% | (0.45%) |
Average Days of Receivables |
296.04 | 319.50 | 329.89 | 149.03 | 17.94 | 181.20 | 168.72 | 123.12 | 138.60 | 251.12 |
Research and Development Expense of Revenue |
56.00% | 74.90% | 74.48% | 29.62% | 0.80% | 9.55% | 9.86% | 9.54% | 11.75% | 17.46% |
Selling, General and Administrative Expense of Revenue |
86.26% | 116.48% | 127.24% | 55.17% | 3.05% | 34.57% | 49.37% | 59.66% | 50.11% | 57.96% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.04% | 2.00% | 1.22% | 1.87% | 0.56% | 3.33% |
Graham Net Nets |
7.40 | 15.25 | 16.07 | 16.77 | 18.83 | 1.22 | 0.41 | 0.46 | 0.19 | 0.15 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.51 | 5.78 | 7.52 | 5.93 | 0.00 |
Earnings Yield |
531.22% | 531.22% | 531.22% | 1,324.11% | 1,335.39% | 16.54% | 6.18% | 8.04% | 7.36% | (0.17%) |
Free Cash Flow Yield |
(110.90%) | (125.26%) | 735.81% | 2,171.52% | 2,389.78% | 54.99% | 4.64% | 0.52% | 10.39% | (8.36%) |
Revenue per Share |
5.37 | 5.03 | 6.55 | 15.00 | 195.09 | 5.16 | 2.59 | 3.55 | 3.06 | 1.27 |
Operating CF per Share |
(7.13) | (0.79) | 1.93 | (7.75) | 154.59 | 4.85 | 0.41 | 0.12 | 1.05 | (0.27) |
Capex per Share |
(0.68) | (1.36) | (2.17) | (4.05) | (7.25) | (1.29) | (0.11) | (0.09) | (0.21) | (0.22) |
Free Cash Flow per Share |
(7.81) | (2.15) | (0.24) | (11.79) | 147.34 | 3.56 | 0.30 | 0.04 | 0.84 | (0.49) |
Cash per Share |
92.39 | 142.16 | 153.47 | 113.78 | 135.19 | 11.99 | 2.17 | 2.74 | 2.03 | 1.15 |
Shareholders Equity per Share |
89.01 | 143.24 | 162.08 | 127.76 | 139.72 | 11.33 | 3.71 | 4.51 | 3.11 | 2.28 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
89.01 | 143.24 | 162.08 | 127.76 | 139.72 | 11.33 | 3.71 | 4.51 | 3.11 | 2.28 |
Free Cash Flow |
(560.89) | (154.32) | (17.51) | (1,173.50) | 14,632.74 | 351.68 | 28.47 | 2.35 | 47.86 | (28.09) |
Working Capital |
5,524.13 | 9,192.61 | 10,304.59 | 11,034.77 | 12,502.26 | 880.68 | 262.41 | 225.97 | 111.35 | 64.48 |
Capital Expenditures |
(48.71) | (97.43) | (156.15) | (402.76) | (719.80) | (127.63) | (10.61) | (5.59) | (11.90) | (12.63) |
Net Current Asset Value |
4,919.03 | 8,600.66 | 9,627.76 | 10,724.49 | 12,042.95 | 779.09 | 249.50 | 206.32 | 81.81 | 49.06 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.05 | 6.31 | 756.23 | 617.63 |
Capex to Sales |
0.13 | 0.27 | 0.33 | 0.27 | 0.04 | 0.25 | 0.04 | 0.02 | 0.07 | 0.17 |
Price to Operating Income |
2.97 | 2.97 | 2.97 | 2.97 | 2.97 | 2.97 | 8.95 | 9.91 | 907.02 | 666.66 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.13 | 0.17 | 0.16 | 0.09 | 0.02 | 0.06 | 0.07 | 0.06 | 0.08 |
Cash ROIC |
(4.15%) | (0.74%) | (0.08%) | (4.88%) | 53.56% | 14.99% | 5.03% | 0.49% | 14.36% | (11.91%) |
Accounts Receivable Turnover |
1.23 | 0.98 | 0.91 | 1.91 | 32.13 | 2.78 | 2.57 | 3.20 | 3.01 | 1.63 |
Accounts Payable Turnover |
0.18 | 0.16 | 0.16 | 0.71 | 1.74 | 0.50 | 0.60 | 0.45 | 0.48 | 0.94 |
Inventory Turnover |
1.30 | 1.21 | 0.93 | 2.46 | 4.46 | 1.01 | 1.23 | 1.11 | 1.20 | 1.37 |
Average Days of Payables |
1,779.43 | 2,083.29 | 2,458.75 | 483.10 | 347.44 | 1,148.72 | 662.01 | 738.05 | 1,071.52 | 406.84 |
Days of Inventory on Hand |
277.53 | 251.45 | 337.05 | 96.37 | 127.83 | 574.90 | 313.03 | 370.43 | 353.78 | 229.86 |
Average Receivables |
314.71 | 370.64 | 517.22 | 780.95 | 602.94 | 183.61 | 95.60 | 71.83 | 58.02 | 44.43 |
Average Payables |
703.84 | 896.12 | 947.58 | 963.29 | 616.04 | 135.16 | 54.44 | 54.70 | 42.19 | 23.81 |
Average Inventory |
95.61 | 116.26 | 158.16 | 278.12 | 240.66 | 66.83 | 26.47 | 22.35 | 16.86 | 16.38 |
Average Assets |
10,439.50 | 12,974.65 | 13,863.30 | 15,431.37 | 9,324.75 | 1,176.81 | 411.04 | 334.50 | 255.29 | 207.14 |
Average Common Equity |
8,344.84 | 10,967.95 | 12,177.56 | 13,294.32 | 7,498.05 | 736.15 | 322.05 | 234.53 | 153.40 | 133.09 |
Columns are period end dates